Immunotherapy improves survival in people with advanced Hodgkin lymphoma, study shows
An immunotherapy approach to treating advanced Hodgkin lymphoma may drastically increase patients’ chances of survival, ...
Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial ...
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), an oncology and obesity company with a diversified portfolio, announced today that it has completed enrollment of the ...
Urogen Pharma (URGN) Receives a Buy from Oppenheimer
In a report released today, Leland Gershell from Oppenheimer maintained a Buy rating on Urogen Pharma (URGN – Research Report), with a ...
TD Cowen Keeps Their Buy Rating on Urogen Pharma (URGN)
In a report released today, Tara Bancroft from TD Cowen maintained a Buy rating on Urogen Pharma (URGN – Research Report). The ...
Boxer Capital, LLC Increases Stake in Tyra Biosciences Inc
On October 10, 2024, Boxer Capital, LLC made a significant addition to its investment portfolio by acquiring 85,939 shares of Tyra Biosciences Inc (NASDAQ:TYRA). This transaction has increased the ...